血清学标志物与结直肠癌相关性研究进展
Research Progress on the Correlation between Serological Markers and Colorectal Cancer
摘要: 癌症早已成为影响人类健康和生活不可忽视的原因。结直肠癌(Colorectal Cancer, CRC)作为消化道最常见肿瘤之一，其发病率和死亡率近年来均保持上升趋势。结直肠癌早期无明显症状并且发病过程漫长，大多患者诊断时已中晚期，因其临床病理分期分型差，恶性程度高，总体生存期不佳。如能早期发现并及时采取相关治疗可提高患者预后。目前研究表明，血清生物标志物可作为监测和早期诊断结直肠癌的有效工具。本文就结直肠癌相关血清生物学指标进行综述，以期为临床提供参考。
Abstract: Cancer has already been a non-negligible cause affecting human health and life. Colorectal cancer (CRC) is one of the most common tumors of digestive tract, and its incidence rate and mortality rate have been on the rise in recent years. The early stage of colorectal cancer is asymptomatic and the course of disease is long. Most patients are diagnosed in the middle and late stage. Due to its poor clinicopathological staging and classification, high degree of malignancy, and poor overall survival time, early detection and timely treatment can improve the prognosis of patients. Current studies have shown that serum biomarkers can be used as effective tools for monitoring and early diagnosis of CRC. This article reviews the serum biological indexes related to colorectal cancer in order to pro-vide reference for clinical practice.
文章引用：姚聚易, 张文斌. 血清学标志物与结直肠癌相关性研究进展[J]. 临床医学进展, 2023, 13(3): 3310-3316. https://doi.org/10.12677/ACM.2023.133471

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] 中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版) [J]. 中华外科杂志, 2020, 58(8): 561-585.
[3] 杨盈, 孟文建, 王自强. 结直肠癌的综合治疗[J]. 中华消化外科杂志, 2022, 21(6): 753-765.
[4] 陈健, 陈波, 王东等. 术前中性粒细胞淋巴细胞比、血小板淋巴细胞比和炎症营养指数对结直肠癌根治术患者预后的预测价值[J]. 肿瘤预防与治疗, 2022, 35(6): 514-519.
[5] 韦斌, 钟晓刚, 麦威, 等. 术前预后营养指数、炎症标志物与结直肠癌患者预后及术后并发症的关系研究[J]. 现代生物医学进展, 2022, 22(4): 746-751.
[6] 邱丽, 谭翠莲, 刘华. 术前NLR、PLR联合血清肿瘤标志物评估结直肠癌患者预后的临床价值[J]. 中国普通外科杂志, 2020, 29(12): 1533-1538.
[7] 赵爽, 王彬潘, 阳莎, 等. 外周血炎症相关指标联合癌胚抗原对结直肠癌的诊断价值[J]. 国际检验医学杂志, 2022, 43(5): 513-518.
[8] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef] 
[9] Yamamoto, T., Kawada, K. and Obama, K. (2021) Inflamma-tion-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients. International Journal of Molecular Sciences, 22, 8002. [Google Scholar] [CrossRef] [PubMed]
[10] Stojkovic, L.M., Pavlovic, M.A., Stankovic, S., et al. (2019) Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer. Disease Markers, 2019, Article ID: 6036979. [Google Scholar] [CrossRef] [PubMed]
[11] Templeton, A.J., McNamara, M.G., Šeruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. JNCI: Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
[12] Alessi, J.V., Ricciuti, B., Alden, S.L., et al. (2021) Low Peripheral Blood Derived Neutrophil-to-Lymphocyte Ratio (dNLR) Is Associated with Increased Tumor T-Cell Infiltration and Favorable Outcomes to First-Line Pembrolizumab in Non-Small Cell Lung Cancer. The Journal for ImmunoTherapy of Cancer, 9, e003536. [Google Scholar] [CrossRef] [PubMed]
[13] Kim, J. and Bae, J.S. (2016) Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment. Mediators of Inflammation, 2016, Article ID: 6058147. [Google Scholar] [CrossRef] [PubMed]
[14] Howard, R., Kanetsky, P.A. and Egan, K.M. (2019) Exploring the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Cancer. Scientific Reports, 9, Article No. 19673. [Google Scholar] [CrossRef] [PubMed]
[15] Fridlender, Z.G., Sun, J., Kim, S., et al. (2009) Polarization of Tumor-Associated Neutrophil Phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell, 16, 183-194. [Google Scholar] [CrossRef] [PubMed]
[16] Chiou, S.H., Sheu, B.C., Chang, W.C., et al. (2005) Current Con-cepts of Tumor-Infiltrating Lymphocytes in Human Malignancies. Journal of Reproductive Immunology, 67, 35-50. [Google Scholar] [CrossRef] [PubMed]
[17] Shankaran, V., Ikeda, H., Bruce, A.T., et al. (2001) IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. Nature, 410, 1107-1111. [Google Scholar] [CrossRef] [PubMed]
[18] Mazaki, J., Katsumata, K., Kasahara, K., et al. (2020) Neutro-phil-to-Lymphocyte Ratio Is a Prognostic Factor for Colon Cancer: A Propensity Score Analysis. BMC Cancer, 20, 922. [Google Scholar] [CrossRef] [PubMed]
[19] 赵贺, 王冲, 张文静, 等. 术前LSR、NLR及PLR检测评估结直肠癌预后的应用价值[J]. 分子诊断与治疗杂志, 2022, 14(2): 228-231+236.
[20] Kang, Y., Zhu, X., Lin, Z., et al. (2021) Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients. Clinical Laboratory, 67. [Google Scholar] [CrossRef] 
[21] 毛富巍, 曹英豪, 邓胜和, 等. 基于NLR、PLR、WLR、MLR的系统炎症标志物评分与结直肠癌患者术后生存时间的相关性[J]. 华中科技大学学报(医学版), 2022, 51(2): 229-234.
[22] Yasui, K., Shida, D., Nakamura, Y., et al. (2021) Postoperative, but Not Preoperative, Inflamma-tion-Based Prognostic Markers Are Prognostic Factors in Stage III Colorectal Cancer Patients. British Journal of Cancer, 124, 933-941. [Google Scholar] [CrossRef] [PubMed]
[23] Bailey, S.E., Ukoumunne, O.C., Shephard, E., et al. (2017) How Useful Is Thrombocytosis in Predicting an Underlying Cancer in Primary Care? A Systematic Review. Family Practice, 34, 4-10. [Google Scholar] [CrossRef] [PubMed]
[24] Goubran, H.A., Stakiw, J., Radosevic, M., et al. (2014) Platelets Effects on Tumor Growth. Seminars in Oncology, 41, 359-369. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, X.R., Yousef, G.M. and Ni, H. (2018) Cancer and Platelet Crosstalk: Opportunities and Challenges for Aspirin and Other Antiplatelet Agents. Blood, 131, 1777-1789. [Google Scholar] [CrossRef] [PubMed]
[26] Lu, C., Gao, P., Yang, Y., et al. (2017) Prognostic Evaluation of Platelet to Lymphocyte Ratio in Patients with Colorectal Cancer. Oncotarget, 8, 86287-86295. [Google Scholar] [CrossRef] [PubMed]
[27] 杨战锋, 郭晓磊, 郭魁元, 等. 炎症标志物对结直肠癌患者预后影响的临床研究[J]. 医学研究杂志, 2023, 52(1): 143-147+142.
[28] Yang, L., He, W., Kong, P., et al. (2017) Clinical Baseline and Prognostic Difference of Platelet Lymphocyte Ratio (PLR) in Right-Sided and Let-Sided Colon Cancers. BMC Cancer, 17, 873. [Google Scholar] [CrossRef] [PubMed]
[29] Yang, Q., Sun, C. and Zhao, L. (2022) Expression and Predictive Value of Serum NLR, PLR Combined with SAA in Patients with Different Stages of Colorectal Cancer. Frontiers in Surgery, 9, Article ID: 906074. [Google Scholar] [CrossRef] [PubMed]
[30] 李东, 盛伟伟, 史晓洋, 等. 术前NLR-PLR评分与结直肠癌临床病理特征及预后关系的研究[J]. 中华消化外科杂志, 2020(3): 308-314.
[31] Tan, D., Fu, Y., Su, Q., et al. (2016) Prognostic Role of Platelet-Lymphocyte Ratio in Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 95, e3837. [Google Scholar] [CrossRef] 
[32] 黄利军, 方佳峰, 吴珏堃, 等. 术前血清肿瘤标志物联合血常规指标对结直肠癌患者预后评估的价值[J]. 中华胃肠外科杂志, 2018, 21(12): 1421-1426.
[33] 刘炬, 徐志坚, 张凯, 等. 体检人员常见肿瘤标志物异常的临床意义[J]. 中国肿瘤, 2013, 22(12): 1029-1032.
[34] Rao, H., Wu, H., Huang, Q., et al. (2021) Clinical Value of Serum CEA, CA24-2 and CA19-9 in Pa-tients with Colorectal Cancer. Clinical Laboratory, 67. [Google Scholar] [CrossRef] 
[35] Peng, H.X., Yang, L., He, B.S., et al. (2017) Combination of Preoperative NLR, PLR and CEA Could Increase the Diagnostic Efficacy for I-III Stage CRC. Journal of Clinical Laboratory Analysis, 31, e22075. [Google Scholar] [CrossRef] [PubMed]
[36] Duffy, M.J. (2001) Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful? Clinical Chemistry, 47, 624-630. [Google Scholar] [CrossRef] 
[37] Becerra, A.Z., Probst, C.P., Tejani, M.A., et al. (2016) Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database. Annals of Surgical Oncology, 23, 1554-1561. [Google Scholar] [CrossRef] [PubMed]
[38] Fu, M.-S., et al. (2022) Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer. Canadian Journal of Gastroenterology and Hepatology, 2022, Article ID: 3109165. [Google Scholar] [CrossRef] [PubMed]
[39] Du, F.Q., et al. (2022) Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients than T4 Stage and Preopera-tive CEA. Frontiers in Oncology, 11, Article ID: 758509. [Google Scholar] [CrossRef] [PubMed]
[40] Sonoda, H., Yamada, T., Matsuda, A., et al. (2021) Elevated Serum Carcinoembryonic Antigen Level after Curative Surgery Is a Prognostic Biomarker of Stage II-III Colorectal Cancer. European Journal of Surgical Oncology, 47, 2880-2887. [Google Scholar] [CrossRef] [PubMed]
[41] Lakemeyer, L., Sander, S., Wittau, M., et al. (2021) Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer. Diseases, 9, 21. [Google Scholar] [CrossRef] [PubMed]
[42] Weitz, J.I., Fredenburgh, J.C. and Eikelboom, J.W. (2017) A Test in Context: D-Dimer. Journal of the American College of Cardiology, 70, 2411-2420. [Google Scholar] [CrossRef] [PubMed]
[43] Riva, N., Camporese, G., Iotti, M., et al. (2018) Age-Adjusted D-Dimer to Rule Out Deep Vein Thrombosis: Findings from the Palladio Algorithm. Journal of Thrombosis and Hae-mostasis, 16, 271-278. [Google Scholar] [CrossRef] [PubMed]
[44] Wada, H., Kobayashi, T., Abe, Y., et al. (2006) Ele-vated Levels of Soluble Fibrin or D-Dimer Indicate High Risk of Thrombosis. Journal of Thrombosis and Haemostasis, 4, 1253-1258. [Google Scholar] [CrossRef] [PubMed]
[45] Clouston, H.W., Rees, P.A., Shaker, H., et al. (2016) PO-32-Patient, Tumour and Operative Factors Influencing Perioperative Hypercoagulability in Colorectal Cancer. Thrombosis Research, 140, S188. [Google Scholar] [CrossRef] 
[46] 刘应超. 结直肠癌患者D-二聚体检测的临床意义[J]. 结直肠肛门外科, 2018, 24(S2): 101-102.
[47] 梁巍, 胡雨薇, 应媛媛. 联合检测D-二聚体、糖类抗原-199、癌胚抗原在结直肠癌患者中的临床价值[J]. 中国实验诊断学, 2019, 23(1): 83-85.
[48] Tekeşin, K., Bayrak, S., Esatoğlu, V., et al. (2016) D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival. Gastroenterology Research and Practice, 2016, Article ID: 4295029. [Google Scholar] [CrossRef] [PubMed]
[49] 张成大, 何君, 黄婷, 等. 结直肠癌患者血清CEA和D-二聚体检测临床意义[J]. 中华肿瘤防治杂志, 2018, 25(4): 282-286.
[50] 芦婷婷, 王治博. 术前血浆纤维蛋白原和D-二聚体水平与结直肠癌预后的关系[J]. 中国医科大学学报, 2018, 47(6): 513-518.
[51] Lin, Y., Liu, Z., Qiu, Y., et al. (2018) Clinical Significance of Plasma D-Dimer and Fibrinogen in Digestive Cancer: A Systematic Review and Me-ta-Analysis. European Journal of Surgical Oncology, 44, 1494-1503. [Google Scholar] [CrossRef] [PubMed]

为你推荐